<code id='714B09FABC'></code><style id='714B09FABC'></style>
    • <acronym id='714B09FABC'></acronym>
      <center id='714B09FABC'><center id='714B09FABC'><tfoot id='714B09FABC'></tfoot></center><abbr id='714B09FABC'><dir id='714B09FABC'><tfoot id='714B09FABC'></tfoot><noframes id='714B09FABC'>

    • <optgroup id='714B09FABC'><strike id='714B09FABC'><sup id='714B09FABC'></sup></strike><code id='714B09FABC'></code></optgroup>
        1. <b id='714B09FABC'><label id='714B09FABC'><select id='714B09FABC'><dt id='714B09FABC'><span id='714B09FABC'></span></dt></select></label></b><u id='714B09FABC'></u>
          <i id='714B09FABC'><strike id='714B09FABC'><tt id='714B09FABC'><pre id='714B09FABC'></pre></tt></strike></i>

          
          WSS
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Leave your comment

          Please enter your name
          Please enter your comment

          fashion